Evaluation of Positioning Protocols on a Wheelchair in Hemiplegic Patients
Launched by HÔPITAL NOVO · Feb 12, 2020
Trial Information
Current as of May 03, 2025
Completed
Keywords
ClinConnect Summary
The stroke is the main cause of hemiplegia in developed countries. Fifteen percent of people who say they have a stroke need, at home, a wheelchair to get from one room to another. The use of a wheelchair can cause postural disorders which can lead to pain, orthopedic deformity and pressure ulcers.
This study aims to assess the interest of using wheelchair positioning equipment (Seat back, Positioning cushion and Belt) on the decrease of postural disorders.
This decrease will be assessed after a standardized course, performed under three different conditions: with the positioning equipmen...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Hemiplegic patient following a stroke
- • Hospitalized in a follow-up and rehabilitative care service, after hospital stays in a MCO service (neurology, neurosurgery or reanimation)
- • With a planned exit from hospital (homecoming, residential care facilities, nursing home, Long Term Care Unit ...)
- • Patient whose wheelchair choice should be already done
- • Patient who propels the wheelchair with the valid hand and/or valid foot
- • Written informed consent (IC) obtained
- • Patients with affiliation to the social security system
- Exclusion Criteria:
- • Good walk recovery (FAC scale \>3)
- • Wheelchair with a double hand rim
- • Patient who cannot use his2 wheelchair independently
- • Cognitive disorders which prevent the ability to well understanding the instructions
- • Other pathology which can interfere with this protocol (Spinal disorder, morbid overweight (BMI\>40...)
About Hôpital Novo
Hôpital Novo is a leading clinical trial sponsor dedicated to advancing medical research and improving patient outcomes through innovative studies and rigorous scientific methodologies. With a strong emphasis on collaboration and ethical practices, Hôpital Novo partners with healthcare professionals and institutions to conduct high-quality clinical trials across various therapeutic areas. Their commitment to patient safety, data integrity, and regulatory compliance ensures that all research initiatives are conducted to the highest standards, ultimately contributing to the development of new treatments and therapies that enhance healthcare delivery.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Toulouse, , France
Aincourt, , France
Fouquières Lès Lens, , France
Lay Saint Christophe, , France
Lille, , France
Menucourt, , France
Garche, , France
Mantes La Jolie, , France
Patients applied
Trial Officials
Nadine Pellegrini
Principal Investigator
Groupement Hospitalier Intercommunal du Vexin
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials